Nilsine Partners LLC Sells 7,507 Shares of Intuitive Surgical, Inc. $ISRG

Nilsine Partners LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 51.8% during the 3rd quarter, Holdings Channel reports. The firm owned 6,986 shares of the medical equipment provider’s stock after selling 7,507 shares during the period. Nilsine Partners LLC’s holdings in Intuitive Surgical were worth $3,124,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Tobam lifted its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new stake in shares of Intuitive Surgical during the second quarter worth about $27,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the period. 1248 Management LLC purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC bought a new position in Intuitive Surgical in the 2nd quarter worth approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 22,806 shares of the company’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the transaction, the insider directly owned 2,694 shares in the company, valued at approximately $1,537,977.66. This represents a 89.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 114,007 shares of company stock valued at $63,533,844 over the last 90 days. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 3.2%

ISRG opened at $559.52 on Tuesday. The stock has a 50-day moving average of $531.81 and a 200 day moving average of $505.39. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market cap of $200.58 billion, a P/E ratio of 74.01, a P/E/G ratio of 4.98 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ISRG shares. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. The Goldman Sachs Group increased their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Leerink Partners lifted their target price on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Finally, UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $608.79.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.